Phase 1b/2 study of margetuximab (M) plus pembrolizumab (P) in advanced HER2+gastroesophageal junction (GEJ) or gastric (G) adenocarcinoma (GEA).

Published

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Catenacci, DVT; Park, H; Lockhart, AC; Gold, PJ; Enzinger, PC; Nordstrom, JL; Hong, S; Hochster, HS; Kelly, RJ; Uronis, HE; Bendell, JC; Oh, SC; Park, SH; Kim, YH; Kang, Y-K; Lee, K-W; Ng, MCH; Wigginton, JM; Davidson-Moncada, JK; Bang, Y-J

Published Date

  • February 1, 2018

Published In

Volume / Issue

  • 36 / 4

Published By

Pages

  • 1

Electronic International Standard Serial Number (EISSN)

  • 1527-7755

International Standard Serial Number (ISSN)

  • 0732-183X

Conference Name

  • Gastrointestinal Cancers Symposium

Conference Location

  • San Francisco, CA

Conference Start Date

  • January 18, 2018

Conference End Date

  • January 20, 2018